Introduction
In 1917 SLEMONS and BOGERT [8] were the first to report an association between serum uric acid (SUA) levels and preeclampsia (PE) and in 1934 STANDER and CADDEN [9] first demonstrated a correlation between SUA concentration and the severity of PE. Since then numerous articles have been published which conclude that elevated uricemia in hypertensive pregnancies is associated with poor perinatal results.
The mechanism that produces this elevation of SUA concentration has not been clearly defined yet, but as SAGEN [6] and DUMONT [2] have suggested, it may result from increased blood lactate levels due to anaerobic metabolism of the uteroplacental unit. An increased SUA concentration may also be affected by impaired uric acid clearance caused by maternal hemoconcentration [4] The aim of our study was to analyze the possible correlation between the highest levels of SUA observed in hypertensive pregnant patients during the third trimester of gestation, the severity of PE and the perinatal outcome.
Material and methods
Maximum concentrations of uricernia were selected in 215 hypertensive pregnant women during the third trimester of pregnancy. Of these 215 patients, 100 had mild PE, 25 had severe PE, 70 had essential hypertension (EH) and 20 had EH and superimposed PE (EH + PE). We categorized hypertension in pregnancy as mild in the range Mean uricemia and the occurrence of SUA levels of 6 mg% or higher were estimated for each group of patients. The results obtained were then correlated with perinatal results. The proportion of patients with SUA concentrations of 6 mg% or higher was significantly greater in women with severe PE and with EH + PE than in those with mild PE and EH (table II) .
Results
Gestational age at delivery and mean birth weight were found to be significantly lower, and low birth weight for gestational age significantly higher, in the severe PE and EH + PE groups than in the remaining groups (table III) . When the patients in each of the groups were analyzed in terms of uricemia equal to or higher than 6 mg%, no correlation could be found between SUA levels and birth weight (table IV) .
Discussion
REDMAN et al [5] , FADEL et al [3] and VARMA [10] reported that SUA levels for PE patients were markedly elevated as compared with EH women, whose uricemia was in turn higher than in normal pregnant women.
Our study demonstrates that mean SUA concentration is significantly higher in severe PE (6.22 mg% ± 1.30 mg%) and EH + PE patients (6.09 mg% ± 1.53 mg%) than in mild PE (4.85 mg% ± 1.34 mg%) and EH patients (4.95 mg% ± 1.22 mg%), where uricemia is higher than in normal pregnancy (3.99 mg% ± 0.99 mg%) but still well below that in severe PE and EH + PE cases.
Several authors [1, 3, 4, 5, 6, 7, 10] have stated that hyperuricemia associated with a hypertensive pregnancy increases the incidence of intrauterine growth retardation, low birth weight and severe fetal distress.
VARMA [10] noted that in mild hypertension the prognosis for the fetus is affected. Our findings, when mean SUA levels and mean birth weight in all the groups were considered together, agreed with those reported by VARMA. When SUA levels and birth weight were studied within each group, no significant correlation was found. In our study, hyperuricemia was closely related to the severity of hypertension, and we did not find high SUA levels in women with mild hypertension.
We conclude that the determination of uric acid levels for the clinical screening of pregnancy complicated by hypertension is an easy and inexpensive method useful for the evaluation of perinatal results which are associated with the severity of the preeclamptic syndrome.
Summary
Maximum serum uric acid (SUA) levels during the third trimester of pregnancy were selected in 215 hypertensive pregnant women: 100 with mild preeclampsia (PE), 25 with severe PE, 70 with essential hypertension (EH) and 20 with EH with superimposed PE (EH + PE). The increase in SUA levels was statistically significant in women with severe PE (6.22 mg% ± 1.30 mg%) and with EH + PE (6.09 mg% ± 1.53 mg%) when compared with values in mild PE and EH women (4.85 mg% ± 1.34mg% and 4.95 mg% ± 1.22 mg%, respectively).
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A significant decrease in average gestational age at delivery and a greater percentage of small-for-gestational age newborns were observed in women with severe PE and EH + PE, compared with patients with mild PE and EH. No correlation within the groups was found between SUA levels and fetal weight. To conclude, the determination of SUA concentration for the clinical screening of a pregnancy complicated by hypertension is an easy and inexpensive method for the prediction of perinatal results associated with severe PE. 
